India Cancer Institute installs Varian RapidArc

Sarah Lamberti | | Health Imaging | Oncology Imaging
Clinicians at the Yashoda Cancer Institute in Hyderabad, India, have performed radiotherapy treatment using RapidArc technology from Varian Medical Systems.

The Palo Alto, Calif.-based Varian said its RapidArc technology makes it possible to deliver image-guided intensity modulated radiotherapy (IMRT) two to eight times faster than is possible with conventional IMRT. RapidArc delivers a precise treatment in single or multiple arcs around the patient.

Yashoda Cancer Institute is a 200-bed comprehensive cancer research and treatment center operated by Yashoda Hospitals; the facility provides healthcare to 7,000 cancer patients every year.



Sarah Lamberti

Related Content

MRI-first approach could allow many to safely forego prostate biopsy
MRI guidance significantly reduces radiotherapy side effects compared to CT
Interventional procedure often as effective as surgery for difficult-to-treat liver cancer
AI tumor volume estimations could improve prostate cancer treatment strategies
MRI could be 'powerful tool' for guiding surgery decisions in patients with rectal cancer
Breast cancer only visible via MRI is often less aggressive

Around the web

Radiology Business
The biggest challenges facing radiology business managers in 2025

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.